![Jeffrey Donohue](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Donohue
Corporate Officer/Principal presso Novartis Institutes for Biomedical Research, Inc.
Profilo
Jeffrey Donohue is currently working as a Corporate Counsel at Novartis Institutes for Biomedical Research, Inc. He previously worked as an Independent Non-Executive Director at Spectra Systems Corp.
from 2012 to 2016.
He has a graduate degree from Boston University and an undergraduate degree from Brandeis University.
Posizioni attive di Jeffrey Donohue
Società | Posizione | Inizio |
---|---|---|
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Jeffrey Donohue
Società | Posizione | Fine |
---|---|---|
SPECTRA SYSTEMS CORPORATION | Direttore/Membro del Consiglio | 31/05/2016 |
Formazione di Jeffrey Donohue
Boston University | Graduate Degree |
Brandeis University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SPECTRA SYSTEMS CORPORATION | Electronic Technology |
Aziende private | 1 |
---|---|
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Jeffrey Donohue